Literature DB >> 16392120

Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis.

Shin J Oh1, Yuki Hatanaka, Shoji Hemmi, Angela M Young, Mia L Scheufele, Sharon P Nations, Liang Lu, Gwen C Claussen, Gil I Wolfe.   

Abstract

To better define electrophysiological abnormalities in myasthenia gravis (MG) patients with muscle-specific tyrosine kinase (MuSK) antibodies (Ab), we compared electrophysiological features of 14 MuSK Ab-positive, 73 acetylcholine receptor antibody (AChR Ab)-positive, and 22 MuSK and AChR Ab-negative (seronegative) patients with generalized disease. Repetitive nerve stimulation (RNS) abnormalities were observed in 86% of MuSK Ab-positive and 82% of AChR Ab-positive patients but in only 55% of seronegative patients. RNS decrements in the orbicularis oculi were more common and severe in the MuSK Ab-positive patients than the other two groups. Single-fiber electromyography (SFEMG) of the extensor digitorum communis was abnormal in 90% of MuSK Ab-positive patients. The high frequency of RNS abnormalities in facial muscles in the MuSK Ab-positive population reflects the propensity for facial muscle involvement in this form of MG and emphasizes the importance of including facial muscles in RNS protocols when evaluating these patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16392120     DOI: 10.1002/mus.20498

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

Review 1.  Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.

Authors:  Michael H Rivner; Mamatha Pasnoor; Mazen M Dimachkie; Richard J Barohn; Lin Mei
Journal:  Neurol Clin       Date:  2018-05       Impact factor: 3.806

2.  Neurophysiological challenges in myasthenia gravis associated with MuSK antibodies: a case report.

Authors:  Gabriele Monte; Amelia Evoli; Donald B Sanders; Anna Modoni
Journal:  Neurol Sci       Date:  2022-04-19       Impact factor: 3.830

Review 3.  The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.

Authors:  Inga Koneczny; Judith Cossins; Angela Vincent
Journal:  J Anat       Date:  2013-03-04       Impact factor: 2.610

Review 4.  History of Myasthenia Gravis Revisited.

Authors:  Feza Deymeer
Journal:  Noro Psikiyatr Ars       Date:  2020-11-07       Impact factor: 1.339

5.  Inferring novel genes related to colorectal cancer via random walk with restart algorithm.

Authors:  Sheng Lu; Zheng-Gang Zhu; Wen-Cong Lu
Journal:  Gene Ther       Date:  2019-07-15       Impact factor: 5.250

6.  Myasthenia gravis: MuSK MG, late-onset MG and ocular MG.

Authors:  Feza Deymeer
Journal:  Acta Myol       Date:  2020-12-01

7.  Clinical features, treatment and prognosis of MuSK antibody-associated myasthenia gravis in Northwest China: a single-centre retrospective cohort study.

Authors:  Sijia Zhao; Kai Zhang; Kaixi Ren; Jiarui Lu; Chao Ma; Cong Zhao; Zhuyi Li; Jun Guo
Journal:  BMC Neurol       Date:  2021-11-04       Impact factor: 2.474

8.  Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status.

Authors:  Shin Joong Oh
Journal:  J Clin Neurol       Date:  2009-06-30       Impact factor: 3.077

9.  The Myotonic Plot Thickens: Electrical Myotonia in Antimuscle-Specific Kinase Myasthenia Gravis.

Authors:  Marcus Magnussen; Ioannis Karakis; Taylor B Harrison
Journal:  Case Rep Neurol Med       Date:  2015-12-03

10.  Repetitive Nerve Stimulation in MuSK-Antibody-Positive Myasthenia Gravis.

Authors:  Seung Woo Kim; Mun Kyung Sunwoo; Seung Min Kim; Ha Young Shin; Il Nam Sunwoo
Journal:  J Clin Neurol       Date:  2017-05-15       Impact factor: 3.077

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.